MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
|
 |
© WTO |
Controversy at customs - the detention of medicines in transit: what impact on access to medicines?
Wednesday 30 September 2009, 14:15 to 16:15
WTO building, Room A
To hear the complete audio of the workshop, download the WTO recording here. (MP3 WTO link)
To read a summary of the event by Intellectual Property Watch, visit "WTO Forum: Bypassing International Agreements May Hamper Medicines Access", (11 October 2009).
Recent detainments by European Union countries’ customs authorities of legitimate generic medicines transiting through the EU on their way to developing countries, have attracted the criticism of WTO Member States and civil society alike. Conducted on the grounds of suspected patent or trademark infringements, the detentions intercept legitimate trade, and could impact the affordability and availability of generic medicines in developing countries.
The incidents highlight questions about the compatibility of EC customs Regulation 1383/2003 and proposed provisions in free trade agreements with WTO Member States obligations under the TRIPS Agreement, in particular the Doha Declaration on the TRIPS Agreement and Public Health, and in relation to GATT.
MSF will explore the legal and practical effect of these issues for access to medicines in developing countries, in a roundtable with academics, member states, suppliers of medicines, civil society organisations and representatives of the pharmaceutical industry.
Introduction
Chair : Michelle Childs, Policy & Advocacy Director, MSF Campaign for Access to Essential Medicines
Panel of speakers
Prof Carlos Correa, University of Buenos Aires
Sunjay Sudhir, Counsellor, Permanent Mission of India to WTO
Luc Devigne, Head of IP Unit, DG Trade, European Commission
Amb. Dr. Tom Mboya Okeyo, Ambassador/Deputy Permanent Representative of Kenya
José Estanislau do Amaral Souza Neto, Counsellor, Permanent mission of Brazil to WTO
Panel of respondents
Arnout Gieske, Lawyer at Van Diepen Van der Kroef, Amsterdam
Edwin de Voogd, Managing Director, IDA Foundation
Representative of the pharmaceutical industry, tbc
Niccolo Rinaldi, Member of the European Parliament
Antony Taubman, Director, Intellectual Property Division, World Trade Organization
Discussion & questions open to the floor
Papers from academics and organisations related to the issue:
The South Center exposes the seizures of generic essential drugs by EU customs officials. To see a good overview of this, click here.
For the legal discussion whether this is allowed under TRIPS, click here.
To download Xavier Seuba's paper entitled, 'Border Measures Concerning Goods Allegedly Infringing Intellectual Property Rights: The Seizures of Generic Medicines in Transit', click here. (PDF)
To download Frederic Abbott's article 'Worst Fears Realised: The Dutch Confiscation of Medicines Bound from India to Brazil', click here. (PDF)
To download 'The Push for Stronger Enforcement Rules: Implications for Developing Countries' by Carlos Correa, click here. (PDF)
Additional resources related to the issue:
To read the Dutch position from September 6, 2009 by Frank Heemskerk, State Secretary of Economic Affairs and Minister for Foreign Trade, click here 
.
To read the European Commission's explanatory note to the EU MSs and MEPs, click here.
Last updated: 23 October 2009
FATAL FLAWS: How Kenya's 2008 Anti-Counterfeit Act could endanger access to medicines 
Presenation: Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun
